ILT6/CD85e/LILRA3 Antibody [Alexa Fluor® 350]

Alexa Fluor (R) products are provided under an intellectual property license from Life Technologies Corporation. The purchase of this product conveys to the buyer the non-transferable right to use the purchased product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components, or any materials made using the product or its components, in any activity to generate revenue, which may include, but is not limited to use of the product or its components: (i) in manufacturing; (ii) to provide a service, information, or data in return for payment; (iii) for therapeutic, diagnostic or prophylactic purposes; or (iv) for resale, regardless of whether they are resold for use in research. For information on purchasing a license to this product for purposes other than as described above, contact Life Technologies Corporation, 5791 Van Allen Way, Carlsbad, CA 92008 USA or outlicensing@lifetech.com. This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.

LILRA3, also known as Leukocyte immunoglobulin-like receptor subfamily A member 3, has 3 isoforms, a 439 amino acid isoform that is 47 kDa, a 375 amino acid isoform that is 40 kDa, and a 456 amino acid isoform that is 49; detected in B-cells, and at lower levels in natural killer (NK) cells, and in peripheral blood monocytes and lung; lacks a transmembrane region and is presumed to be a soluble receptor and may act as soluble receptor for class I MHC antigens. Studies on this protein have shown relationship with the following diseases and disorders: multiple sclerosis, rheumatoid arthritis, arthritis, ascariasis, trichuriasis, multiple sclerosis, rheumatism, interferon, and hepatitis c. This protein has been shown to interact with EWSR1 and USP46 proteins in osteoclast differentiation, defense response, and signal transduction pathways.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Array NBP3-00150AF350

• ILT6/CD85e/LILRA3 Antibodies
• ILT6/CD85e/LILRA3 Antibody Pair
• ILT6/CD85e/LILRA3 ELISA Kits
• ILT6/CD85e/LILRA3 Lysate
• ILT6/CD85e/LILRA3 Proteins and Enzyme